What is AMN Healthcare Services's earnings per share (EPS)?

AMN Healthcare Services (AMN) reported diluted earnings per share of -$2.48 for fiscal year 2025. This represents a 35.6% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

AMN Healthcare Services (AMN) Financials

AMN

Trailing 12 months to June 30, 2026

Revenue $3.4B +24.0% YoY

Net Income $104.9M +135.2% YoY

EPS (Diluted) $2.69 +134.6% YoY

Free Cash Flow $439.1M +71.9% YoY

Market Cap $1.4B as of Oct 14, 2026

Price / Sales 0.4x on $3.4B revenue, trailing 12 months to June 30, 2026

Price / Earnings 13.5x on $104.9M net income, trailing 12 months to June 30, 2026

Price / Book 1.9x on $741.3M equity, Q2 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 14, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Aug 7, 2026 Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Aug 7, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the AMN SEC filings page.

AMN Healthcare Services (AMN) reported $3.4B in revenue over the twelve months to Jun 30, 2026, up 24.0% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI AMN FY2025 2026-10-03

Revenue has fallen for three straight years, while positive free cash flow persists but profitability and liquidity have weakened.

In FY2025, a net loss of $95.7M coexisted with operating cash flow of $269.5M; the gap partly reflects non-cash charges rather than equivalent cash consumption. Depreciation and amortization of $156.6M explains much of that difference, so cash generation currently overstates the strength of the underlying profit engine.

Gross margin slipped from 32.7% in FY2022 to 28.4% in FY2025. Operating margin moved from 12.3% to -2.0%, indicating the revenue contraction exposed costs that did not contract as quickly.

Current ratio fell from 1.1x in FY2024 to 0.9x in FY2025, so near-term asset coverage moved below parity. Debt-to-equity eased from 1.5x to 1.2x, meaning leverage improved even as short-term liquidity tightened.

Financial Health Signals

Financial Health Score 25/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of AMN Healthcare Services's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

AMN Healthcare Services has an operating margin of -2.0%, meaning the company loses $2 on every $100 of revenue. This results in a profitability score of 30/100. This is up from -3.4% the prior year.

Growth

AMN Healthcare Services's revenue declined 8.5% year-over-year, from $3.0B to $2.7B. This contraction results in a growth score of 6/100.

Leverage

AMN Healthcare Services has elevated debt relative to equity (D/E of 1.19), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 7/100, reflecting increased financial risk.

Liquidity

AMN Healthcare Services's current ratio of 0.94 is below the typical benchmark, resulting in a score of 16/100. This tight liquidity could limit financial flexibility if cash inflows slow.

Cash Flow

AMN Healthcare Services has a free cash flow margin of 8.6%, earning a moderate score of 59/100. The company generates positive cash flow after capital investments, but with room for improvement.

Returns

AMN Healthcare Services posts a -14.9% return on equity (ROE), meaning it loses $15 for every $100 of shareholders' equity. This results in a returns score of 31/100. This is up from -20.8% the prior year.

Altman Z-Score Grey Zone

2.59

AMN Healthcare Services scores 2.59, placing it in the grey zone between 1.81 and 2.99. This signals moderate financial risk that warrants monitoring.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Neutral

5/9

AMN Healthcare Services passes 5 of 9 financial strength tests. 3 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality Mixed

N/A

AMN Healthcare Services reported a net loss of $95.7M while generating $269.5M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal.

Interest Coverage At Risk

N/A

AMN Healthcare Services reported an operating loss of $55.5M against $45.6M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$673.2M

YoY+2.3%

QoQ-51.2%

5Y CAGR-4.7%

10Y CAGR+3.6%

AMN Healthcare Services generated $673.2M in revenue in Q2 2026. This represents an increase of 2.3% from the same quarter a year earlier. Against the prior quarter it is down 51.2%.

EBITDA

$58.5M

YoY+168.0%

QoQ-61.7%

5Y CAGR-13.9%

AMN Healthcare Services's EBITDA was $58.5M in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 168.0% from the same quarter a year earlier. Against the prior quarter it is down 61.7%.

Net Income

$21.2M

YoY+118.2%

QoQ-66.0%

5Y CAGR-20.5%

10Y CAGR-2.2%

AMN Healthcare Services reported $21.2M in net income in Q2 2026. This represents an increase of 118.2% from the same quarter a year earlier. Against the prior quarter it is down 66.0%.

EPS (Diluted)

$0.53

YoY+117.5%

QoQ-66.7%

5Y CAGR-17.5%

10Y CAGR0.0%

AMN Healthcare Services earned $0.53 per diluted share (EPS) in Q2 2026. This represents an increase of 117.5% from the same quarter a year earlier. Against the prior quarter it is down 66.7%.

Cash & Balance Sheet

Free Cash Flow

-$198.5M

YoY-388.7%

QoQ-135.7%

AMN Healthcare Services recorded an outflow of $198.5M in free cash flow in Q2 2026, representing a cash shortfall after capex. This represents a decrease of 388.7% from the same quarter a year earlier. Against the prior quarter it is down 135.7%.

Cash & Debt

$361.8M

YoY+771.8%

QoQ-35.5%

5Y CAGR+21.0%

10Y CAGR+32.9%

AMN Healthcare Services held $361.8M in cash as of Q2 2026; long-term debt is not reported for that period.

Shares Outstanding

39M

YoY+1.1%

QoQ-0.1%

5Y CAGR-3.9%

10Y CAGR-2.1%

AMN Healthcare Services had 39M shares outstanding in Q2 2026. This represents an increase of 1.1% from the same quarter a year earlier. Against the prior quarter it is down 0.1%.

Dividends Per Share

Not reported for Q2 2026.

Margins & Returns

Gross Margin

30.6%

YoY+0.7pp

QoQ+3.8pp

5Y change-2.1pp

10Y change-2.1pp

AMN Healthcare Services's gross margin was 30.6% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is up 0.7 percentage points from the same quarter a year earlier. Against the prior quarter it is up 3.8 percentage points.

Operating Margin

4.0%

YoY+22.8pp

QoQ-4.5pp

5Y change-7.6pp

AMN Healthcare Services's operating margin was 4.0% in Q2 2026, reflecting core business profitability. This is up 22.8 percentage points from the same quarter a year earlier. Against the prior quarter it is down 4.5 percentage points.

Net Margin

3.1%

YoY+20.8pp

QoQ-1.4pp

5Y change-4.7pp

10Y change-2.4pp

AMN Healthcare Services's net profit margin was 3.1% in Q2 2026, showing the share of revenue converted to profit. This is up 20.8 percentage points from the same quarter a year earlier. Against the prior quarter it is down 1.4 percentage points.

Return on Equity

2.9%

YoY+22.0pp

QoQ-5.9pp

5Y change-4.1pp

10Y change-3.7pp

AMN Healthcare Services's ROE was 2.9% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is up 22.0 percentage points from the same quarter a year earlier. Against the prior quarter it is down 5.9 percentage points.

Capital Allocation

Capital Expenditures

$8.5M

YoY-12.9%

QoQ+17.8%

5Y CAGR-5.7%

10Y CAGR+3.1%

AMN Healthcare Services invested $8.5M in capex in Q2 2026, funding long-term assets and infrastructure. This represents a decrease of 12.9% from the same quarter a year earlier. Against the prior quarter it is up 17.8%.

R&D Spending

Not reported for Q2 2026.

Share Buybacks

Not reported for Q2 2026.

AMN Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

AMN quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Revenue	$3.4B	$2.7B-8.5%	$3.0B-21.3%	$3.8B-27.7%	$5.2B+31.6%	$4.0B+66.4%	$2.4B+7.7%	$2.2B+4.0%	$2.1B+7.4%	$2.0B+4.5%	$1.9B+30.0%	$1.5B+41.2%	$1.0B+2.4%	$1.0B+6.1%	$954.0M+7.5%	$887.5M
Cost of Revenue	$2.5B	$2.0B-5.2%	$2.1B-18.7%	$2.5B-28.0%	$3.5B+31.9%	$2.7B+67.0%	$1.6B+8.3%	$1.5B+2.7%	$1.4B+7.1%	$1.3B+4.8%	$1.3B+29.1%	$993.7M+38.0%	$719.9M+0.8%	$714.5M+4.5%	$683.6M+7.1%	$638.1M
Gross Profit	$954.3M	$774.1M-15.8%	$919.4M-26.4%	$1.2B-27.2%	$1.7B+31.1%	$1.3B+65.4%	$791.8M+6.5%	$743.5M+6.8%	$696.4M+8.1%	$644.4M+4.0%	$619.7M+32.0%	$469.4M+48.5%	$316.1M+6.3%	$297.3M+9.9%	$270.4M+8.5%	$249.3M
SG&A Expenses	$656.5M	$593.0M-6.2%	$632.5M-15.5%	$748.4M-20.1%	$936.6M+28.2%	$730.5M+32.9%	$549.7M+8.2%	$508.0M+12.3%	$452.3M+13.2%	$399.7M+0.3%	$398.5M+24.7%	$319.5M+37.6%	$232.2M+6.4%	$218.2M+7.6%	$202.9M+3.9%	$195.3M
Operating Income	$199.8M	-$55.5M+46.0%	-$102.7M-130.3%	$338.4M-47.7%	$647.1M+35.4%	$478.0M+220.2%	$149.3M-15.6%	$176.9M-12.8%	$202.8M-4.5%	$212.4M+10.9%	$191.6M+48.7%	$128.9M+89.8%	$67.9M+3.7%	$65.5M+22.8%	$53.3M+41.7%	$37.6M
EBITDA	N/A	$101.1M+42.2%	$71.1M-85.8%	$499.4M-36.3%	$784.2M+34.8%	$581.7M+138.9%	$243.5M+3.4%	$235.4M-3.5%	$244.1M-0.3%	$244.7M+10.6%	$221.3M+47.7%	$149.8M+78.6%	$83.9M+6.1%	$79.0M+17.1%	$67.5M+25.1%	$54.0M
Interest Expense	$35.6M	$45.6M-34.8%	$69.9M+29.1%	$54.1M+34.0%	$40.4M+18.5%	$34.1M-41.0%	$57.7M+103.1%	$28.4M+76.1%	$16.1M-18.0%	$19.7M+27.2%	$15.5M+98.5%	$7.8M-15.7%	$9.2M-4.4%	$9.7M-62.9%	$26.0M+9.7%	$23.7M
Income Tax	$59.3M	-$5.4M+79.1%	-$25.6M-134.8%	$73.6M-54.7%	$162.7M+39.6%	$116.5M+458.7%	$20.9M-39.5%	$34.5M-23.2%	$44.9M-25.3%	$60.2M-14.4%	$70.3M+79.4%	$39.2M+54.0%	$25.4M+11.1%	$22.9M+108.0%	$11.0M+23.7%	$8.9M
Net Income	$104.9M	-$95.7M+34.9%	-$147.0M-169.8%	$210.7M-52.6%	$444.1M+35.6%	$327.4M+363.3%	$70.7M-38.0%	$114.0M-19.6%	$141.7M+6.9%	$132.6M+25.2%	$105.8M+29.2%	$81.9M+146.5%	$33.2M+0.9%	$32.9M+92.2%	$17.1M+165.2%	-$26.3M
EPS (Basic)	N/A	-$2.48+35.6%	-$3.85-171.6%	$5.38-46.0%	$9.96+45.0%	$6.87+361.1%	$1.49-38.9%	$2.44-18.4%	$2.99+7.9%	$2.77+25.3%	$2.21+28.5%	$1.72+142.3%	$0.71-1.4%	$0.72+89.5%	$0.38+157.6%	-$0.66
EPS (Diluted)	$2.69	-$2.48+35.6%	-$3.85-171.8%	$5.36-45.9%	$9.90+45.4%	$6.81+360.1%	$1.48-38.3%	$2.40-17.5%	$2.91+8.6%	$2.68+24.7%	$2.15+28.0%	$1.68+143.5%	$0.690.0%	$0.69+86.5%	$0.37+164.9%	-$0.57
Diluted Shares (Avg)	N/A	39M+0.9%	38M-2.9%	39M-12.3%	45M-6.6%	48M+0.7%	48M+0.2%	48M-2.2%	49M-1.5%	49M+0.3%	49M+0.9%	49M+1.6%	48M+0.6%	48M+2.3%	47M+1.6%	46M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Revenue	$673.2M+2.3%	$1.4B+99.9%	$748.2M+1.8%	$634.5M-7.7%	$658.2M-11.1%	$689.5M-16.0%	$734.7M-10.2%	$687.5M-19.4%
Cost of Revenue	$467.4M+1.2%	$1.0B+105.4%	$553.1M+7.2%	$450.1M-5.1%	$461.8M-9.6%	$491.4M-12.8%	$515.7M-7.5%	$474.5M-15.9%
Gross Profit	$205.9M+4.8%	$368.8M+86.2%	$195.1M-10.9%	$184.4M-13.4%	$196.4M-14.5%	$198.1M-23.1%	$219.0M-16.1%	$213.1M-26.4%
SG&A Expenses	$147.4M-4.7%	$218.4M+47.9%	$152.1M-4.3%	$138.6M-7.4%	$154.6M+3.7%	$147.7M-15.5%	$158.9M-10.5%	$149.7M-8.4%
Operating Income	$26.9M+121.7%	$117.2M+836.8%	$8.1M+104.0%	$47.6M+114.0%	-$123.7M-428.3%	$12.5M-68.7%	-$202.6M-692.8%	$22.3M-74.4%
EBITDA	$58.5M+168.0%	$152.8M+191.9%	$49.7M+131.6%	$85.0M+34.1%	-$86.0M-206.4%	$52.4M-38.0%	-$157.5M-296.3%	$63.4M-49.7%
Interest Expense	$7.0M-38.3%	$6.7M-45.5%	$12.3M-46.9%	$9.6M-33.3%	$11.4M-27.7%	$12.3M-25.9%	$23.1M+14.6%	$14.4M+25.2%
Income Tax	-$1.3M+93.3%	$48.3M+3687.7%	$3.5M+109.3%	$8.7M+962.6%	-$18.9M-429.4%	$1.3M-78.7%	-$38.1M-2615.4%	$819K-96.3%
Net Income	$21.2M+118.2%	$62.2M+5792.9%	-$7.7M+95.9%	$29.3M+319.1%	-$116.2M-815.7%	-$1.1M-106.3%	-$187.5M-1601.6%	$7.0M-86.9%
EPS (Basic)	$0.54+117.9%	$1.60+5433.3%	-$0.19+96.1%	$0.76+322.2%	-$3.02-802.3%	-$0.03-106.7%	-$4.91-1427.0%	$0.18-87.1%
EPS (Diluted)	$0.53+117.5%	$1.59+5400.0%	-$0.19+96.1%	$0.76+322.2%	-$3.02-819.0%	-$0.03-106.7%	-$4.91-1427.0%	$0.18-87.1%
Diluted Shares (Avg)	40M+3.4%	39M+2.1%	N/A	39M+1.1%	38M+0.5%	38M+0.3%	N/A	38M-0.1%

Not reported in any period shown, so not listed: R&D Expenses.

AMN Balance Sheet

AMN quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Total Assets	$2.1B-13.3%	$2.4B-17.4%	$2.9B+1.2%	$2.9B-7.8%	$3.1B+33.1%	$2.4B+21.8%	$1.9B+29.4%	$1.5B+19.0%	$1.3B+5.7%	$1.2B+34.8%	$880.4M+29.3%	$680.7M+12.7%	$604.3M+16.8%	$517.4M-3.4%	$535.6M
Current Assets	$545.4M-8.3%	$594.9M-29.3%	$841.7M-23.0%	$1.1B-18.9%	$1.3B+152.8%	$533.7M-4.8%	$560.5M+16.2%	$482.2M+1.7%	$474.2M+5.2%	$450.6M+20.0%	$375.6M+32.9%	$282.7M+21.4%	$232.9M+14.3%	$203.7M-4.1%	$212.5M
Cash & Equivalents	$34.0M+219.0%	$10.6M-67.7%	$32.9M-49.0%	$64.5M-64.3%	$180.9M+519.3%	$29.2M-64.8%	$83.0M+498.9%	$13.9M-8.5%	$15.1M+42.6%	$10.6M+10.9%	$9.6M-26.7%	$13.1M-16.1%	$15.6M+174.2%	$5.7M+43.4%	$4.0M
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Accounts Receivable	$382.6M-12.6%	$437.8M-29.8%	$623.5M-7.7%	$675.6M-14.4%	$789.1M+109.8%	$376.1M+6.6%	$352.7M-3.6%	$365.9M+4.4%	$350.5M+2.5%	$342.0M+23.0%	$278.0M+49.2%	$186.3M+26.3%	$147.5M+3.5%	$142.5M-2.8%	$146.7M
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$755.8M-15.8%	$897.5M-19.3%	$1.1B+18.8%	$935.4M+4.8%	$892.3M+3.2%	$864.5M+45.2%	$595.6M+35.8%	$438.5M+28.7%	$340.6M-0.3%	$341.8M+66.9%	$204.8M+32.6%	$154.4M+6.7%	$144.6M+17.3%	$123.3M0.0%	$123.3M
Total Liabilities	$1.5B-15.0%	$1.7B-18.3%	$2.1B+13.5%	$1.8B-6.4%	$2.0B+28.4%	$1.5B+28.4%	$1.2B+40.0%	$853.7M+23.5%	$691.4M-6.2%	$737.5M+38.5%	$532.6M+25.6%	$424.1M+9.7%	$386.5M+15.3%	$335.3M-10.8%	$375.9M
Current Liabilities	$577.6M+5.8%	$545.8M-16.8%	$656.1M-23.5%	$857.9M-11.5%	$969.4M+129.2%	$423.0M+11.9%	$378.1M+23.1%	$307.3M+15.8%	$265.3M-3.5%	$274.8M+9.5%	$251.0M+40.8%	$178.3M+24.6%	$143.1M+30.6%	$109.5M-21.8%	$140.1M
Non-Current Liabilities	$874.4M-24.8%	$1.2B-19.0%	$1.4B+45.6%	$986.8M-1.4%	$1.0B-9.9%	$1.1B+36.0%	$816.8M+49.5%	$546.5M+28.2%	$426.2M-7.9%	$462.7M+64.3%	$281.6M+14.5%	$245.9M+1.0%	$243.5M+7.8%	$225.8M-4.3%	$235.8M
Long-Term Debt	$767.1M-27.4%	$1.1B-19.1%	$1.3B+54.7%	$843.5M+0.1%	$842.3M-1.8%	$858.0M+39.0%	$617.2M+40.1%	$440.6M+37.8%	$319.8M-11.0%	$359.2M+98.5%	$181.0M+25.4%	$144.4M-2.9%	$148.7M-6.0%	$158.2M-9.2%	$174.2M
Total Equity	$642.1M-9.1%	$706.6M-15.0%	$831.3M-20.3%	$1.0B-10.2%	$1.2B+41.8%	$819.7M+11.3%	$736.7M+15.3%	$639.0M+13.6%	$562.5M+25.2%	$449.4M+29.2%	$347.9M+35.6%	$256.6M+17.8%	$217.7M+19.6%	$182.1M+34.2%	$135.7M
Retained Earnings	$1.2B-7.3%	$1.3B-10.1%	$1.5B+17.0%	$1.2B+55.7%	$796.9M+69.7%	$469.6M+17.4%	$400.0M+39.8%	$286.1M+101.1%	$142.2M+1370.7%	$9.7M+110.1%	-$96.2M+46.0%	-$178.1M+15.7%	-$211.3M+12.8%	-$242.2M+6.6%	-$259.3M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Total Assets	$2.4B+6.9%	$2.6B+8.7%	$2.1B-13.3%	$2.1B-19.8%	$2.2B-20.2%	$2.4B-16.7%	$2.4B-17.4%	$2.7B+0.5%
Current Assets	$869.3M+52.1%	$1.1B+81.2%	$545.4M-8.3%	$570.3M-6.9%	$571.4M-18.9%	$627.4M-20.7%	$594.9M-29.3%	$612.3M-26.3%
Cash & Equivalents	$361.8M+771.8%	$560.7M+905.3%	$34.0M+219.0%	$52.6M+72.3%	$41.5M-13.6%	$55.8M+10.3%	$10.6M-67.7%	$30.6M+4.0%
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Accounts Receivable	$382.5M-1.4%	$394.7M-6.4%	$382.6M-12.6%	$391.1M-13.3%	$387.8M-23.8%	$421.9M-27.1%	$437.8M-29.8%	$451.1M-20.3%
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$759.0M+0.4%	$755.8M-15.8%	$755.8M-15.8%	$755.8M-32.3%	$755.8M-32.3%	$897.5M-19.5%	$897.5M-19.3%	$1.1B+19.3%
Total Liabilities	$1.6B+1.1%	$1.9B+12.6%	$1.5B-15.0%	$1.5B-15.9%	$1.6B-15.3%	$1.7B-16.8%	$1.7B-18.3%	$1.8B-3.3%
Current Liabilities	$770.5M+34.3%	$1.0B+79.3%	$577.6M+5.8%	$542.2M+4.6%	$573.6M0.0%	$582.2M-6.7%	$545.8M-16.8%	$518.5M-26.7%
Non-Current Liabilities	$852.2M-17.3%	$847.4M-22.8%	$874.4M-24.8%	$952.4M-24.3%	$1.0B-21.9%	$1.1B-21.3%	$1.2B-19.0%	$1.3B+11.3%
Long-Term Debt	N/A	N/A	$767.1M-27.4%	N/A	N/A	N/A	$1.1B-19.1%	N/A
Total Equity	$741.3M+22.0%	$712.8M-0.3%	$642.1M-9.1%	$644.4M-27.6%	$607.6M-30.7%	$715.1M-16.3%	$706.6M-15.0%	$890.7M+9.0%
Retained Earnings	$1.3B+8.8%	$1.3B-2.5%	$1.2B-7.3%	$1.2B-18.5%	$1.2B-20.1%	$1.3B-11.3%	$1.3B-10.1%	$1.5B+3.7%

Not reported in any period shown, so not listed: Inventory.

AMN Cash Flow Statement

AMN quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Cash Flow	$470.8M	$269.5M-15.9%	$320.4M-13.9%	$372.2M-43.1%	$653.7M+114.1%	$305.4M+18.9%	$256.8M+14.2%	$224.9M-0.9%	$227.0M+41.4%	$160.5M+19.9%	$133.9M+137.8%	$56.3M+103.5%	$27.7M-54.0%	$60.2M+3.1%	$58.4M+202.3%	$19.3M
Depreciation & Amortization	N/A	$156.6M-9.9%	$173.8M+8.0%	$160.9M+17.4%	$137.1M+32.2%	$103.7M+10.1%	$94.2M+60.9%	$58.5M+41.9%	$41.2M+27.8%	$32.3M+9.0%	$29.6M+41.4%	$21.0M+31.0%	$16.0M+18.1%	$13.5M-4.3%	$14.2M-13.3%	$16.3M
Stock-Based Compensation	N/A	$30.7M+31.6%	$23.3M+29.4%	$18.0M-40.1%	$30.1M+19.2%	$25.2M+23.2%	$20.5M+26.0%	$16.2M+50.2%	$10.8M+5.6%	$10.2M-10.2%	$11.4M+10.8%	$10.3M+43.7%	$7.2M+16.8%	$6.1M-1.5%	$6.2M-12.4%	$7.1M
Capital Expenditures	$31.6M	$35.6M-56.0%	$80.9M-22.0%	$103.7M+36.7%	$75.8M+41.5%	$53.6M+42.1%	$37.7M+7.1%	$35.2M0.0%	$35.2M+32.7%	$26.5M+20.8%	$22.0M-18.7%	$27.0M+41.2%	$19.1M+111.5%	$9.0M+65.3%	$5.5M+17.7%	$4.6M
Free Cash Flow	$439.1M	$233.8M-2.4%	$239.5M-10.8%	$268.5M-53.5%	$577.9M+129.5%	$251.8M+14.9%	$219.1M+15.5%	$189.6M-1.1%	$191.8M+43.1%	$134.0M+19.7%	$112.0M+282.1%	$29.3M+243.0%	$8.5M-83.3%	$51.1M-3.4%	$52.9M+260.8%	$14.7M
Investing Cash Flow	$31.2M	$4.3M+105.4%	-$79.9M+80.6%	-$412.5M-141.6%	-$170.7M-58.9%	-$107.4M+80.0%	-$538.2M-84.4%	-$291.8M-4.5%	-$279.3M-690.0%	-$35.4M+86.3%	-$258.4M-122.6%	-$116.1M-311.2%	-$28.2M+42.6%	-$49.2M-3217.7%	$1.6M+179.7%	-$2.0M
Financing Cash Flow	-$184.0M	-$295.9M-14.0%	-$259.4M-2518.2%	$10.7M+101.8%	-$591.9M-1596.1%	-$34.9M-116.5%	$211.5M+54.8%	$136.6M+264.2%	$37.5M+148.6%	-$77.2M-161.1%	$126.3M+124.7%	$56.2M+2777.5%	-$2.1M-106.4%	-$1.0M+98.3%	-$58.2M-280.2%	-$15.3M
Share Buybacks	N/A	$0	$0-100.0%	$424.7M-26.4%	$576.8M+21357.1%	$2.7M	$0-100.0%	$18.7M-72.1%	$67.0M+232.3%	$20.2M+52.1%	$13.3M	$0	$0	N/A	N/A	N/A

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Operating Cash Flow	-$189.9M-341.8%	$562.5M+506.9%	$75.6M+3.8%	$22.7M-66.0%	$78.5M-21.1%	$92.7M+13.9%	$72.8M+277.0%	$66.7M-61.3%
Depreciation & Amortization	$31.6M-16.3%	$35.7M-10.5%	$37.2M-10.2%	$37.4M-9.1%	$37.8M-12.4%	$39.9M-10.5%	$41.5M-3.8%	$41.1M+5.0%
Stock-Based Compensation	N/A	$9.9M+5.4%	N/A	N/A	N/A	$9.4M+21.2%	N/A	$5.6M+1715.4%
Capital Expenditures	$8.5M-12.9%	$7.2M-27.4%	$7.9M-51.0%	$7.9M-58.9%	$9.8M-64.1%	$10.0M-45.0%	$16.2M-45.7%	$19.3M-35.6%
Free Cash Flow	-$198.5M-388.7%	$555.2M+571.4%	$67.6M+19.5%	$14.8M-68.9%	$68.7M-4.8%	$82.7M+30.8%	$56.6M+179.7%	$47.4M-66.7%
Investing Cash Flow	-$12.2M+40.7%	-$7.5M+71.2%	-$8.1M+43.3%	$59.0M+368.1%	-$20.6M+7.8%	-$26.0M-21.7%	-$14.2M+95.6%	-$22.0M+35.1%
Financing Cash Flow	-$2.4M+97.1%	-$27.1M+55.7%	-$83.2M-4.2%	-$71.2M-17.8%	-$80.2M-0.1%	-$61.2M-57.1%	-$79.9M-122.0%	-$60.5M+42.4%
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	$0	$0

Not reported in any period shown, so not listed: Dividends Paid.

AMN Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

AMN quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Gross Margin	28.3%-2.5pp	30.8%-2.2pp	33.0%+0.2pp	32.7%-0.1pp	32.9%-0.2pp	33.1%-0.4pp	33.5%+0.9pp	32.6%+0.2pp	32.4%-0.2pp	32.6%+0.5pp	32.1%+1.6pp	30.5%+1.1pp	29.4%+1.0pp	28.3%+0.3pp	28.1%
Operating Margin	-2.0%+1.4pp	-3.4%-12.4pp	8.9%-3.4pp	12.3%+0.3pp	12.0%+5.8pp	6.2%-1.7pp	8.0%-1.5pp	9.5%-1.2pp	10.7%+0.6pp	10.1%+1.3pp	8.8%+2.3pp	6.6%+0.1pp	6.5%+0.9pp	5.6%+1.3pp	4.2%
Net Margin	-3.5%+1.4pp	-4.9%-10.5pp	5.6%-2.9pp	8.5%+0.3pp	8.2%+5.3pp	2.9%-2.2pp	5.1%-1.5pp	6.6%0.0pp	6.7%+1.1pp	5.6%0.0pp	5.6%+2.4pp	3.2%0.0pp	3.3%+1.5pp	1.8%+4.8pp	-3.0%
Return on Equity	-14.9%+5.9pp	-20.8%-46.1pp	25.3%-17.2pp	42.5%+14.4pp	28.2%+19.6pp	8.6%-6.9pp	15.5%-6.7pp	22.2%-1.4pp	23.6%0.0pp	23.5%0.0pp	23.5%+10.6pp	13.0%-2.2pp	15.1%+5.7pp	9.4%+28.8pp	-19.4%
Return on Assets	-4.6%+1.5pp	-6.1%-13.3pp	7.2%-8.2pp	15.4%+4.9pp	10.4%+7.4pp	3.0%-2.9pp	5.9%-3.6pp	9.5%-1.1pp	10.6%+1.7pp	8.9%-0.4pp	9.3%+4.4pp	4.9%-0.6pp	5.5%+2.1pp	3.3%+8.2pp	-4.9%
Current Ratio	0.94-0.1x	1.09-0.2x	1.280.0x	1.27-0.1x	1.39+0.1x	1.26-0.2x	1.48-0.1x	1.57-0.2x	1.79+0.1x	1.64+0.1x	1.50-0.1x	1.590.0x	1.63-0.2x	1.86+0.3x	1.52
Debt-to-Equity	1.19-0.3x	1.49-0.1x	1.57+0.8x	0.81+0.1x	0.72-0.3x	1.05+0.2x	0.84+0.1x	0.69+0.1x	0.57-0.2x	0.80+0.3x	0.520.0x	0.56-0.1x	0.68-0.2x	0.87-0.4x	1.28
Asset Turnover	1.30+0.1x	1.24-0.1x	1.30-0.5x	1.82+0.5x	1.27+0.3x	1.02-0.1x	1.15-0.3x	1.43-0.2x	1.590.0x	1.60-0.1x	1.66+0.1x	1.52-0.2x	1.67-0.2x	1.84+0.2x	1.66
FCF Margin	8.6%+0.5pp	8.0%+0.9pp	7.1%-3.9pp	11.0%+4.7pp	6.3%-2.8pp	9.2%+0.6pp	8.5%-0.5pp	9.0%+2.2pp	6.7%+0.9pp	5.9%+3.9pp	2.0%+1.2pp	0.8%-4.2pp	5.1%-0.5pp	5.5%+3.9pp	1.7%

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Gross Margin	30.6%+0.7pp	26.8%-2.0pp	26.1%-3.7pp	29.1%-1.9pp	29.8%-1.2pp	28.7%-2.6pp	29.8%-2.1pp	31.0%-2.9pp
Operating Margin	4.0%+22.8pp	8.5%+6.7pp	1.1%+28.6pp	7.5%+4.3pp	-18.8%-23.9pp	1.8%-3.1pp	-27.6%-31.8pp	3.2%-7.0pp
Net Margin	3.1%+20.8pp	4.5%+4.7pp	-1.0%+24.5pp	4.6%+3.6pp	-17.7%-19.9pp	-0.2%-2.3pp	-25.5%-27.0pp	1.0%-5.2pp
Return on Equity	2.9%+22.0pp	8.7%+8.9pp	-1.2%+25.3pp	4.5%+3.8pp	-19.1%-21.0pp	-0.1%-2.2pp	-26.5%-28.0pp	0.8%-5.7pp
Return on Assets	0.9%+6.2pp	2.4%+2.4pp	-0.4%+7.4pp	1.4%+1.1pp	-5.3%-5.8pp	-0.1%-0.7pp	-7.8%-8.2pp	0.3%-1.7pp
Current Ratio	1.13+0.1x	1.090.0x	0.94-0.1x	1.05-0.1x	1.00-0.2x	1.08-0.2x	1.09-0.2x	1.180.0x
Debt-to-Equity	2.19-0.5x	2.65+0.3x	1.19-0.3x	2.32+0.3x	2.64+0.5x	2.350.0x	1.49-0.1x	2.00-0.3x
Asset Turnover	0.280.0x	0.53+0.2x	0.36+0.1x	0.300.0x	0.300.0x	0.290.0x	0.300.0x	0.26-0.1x
FCF Margin	-29.5%-39.9pp	40.3%+28.3pp	9.0%+1.3pp	2.3%-4.6pp	10.4%+0.7pp	12.0%+4.3pp	7.7%+16.4pp	6.9%-9.8pp

Note: The current ratio is below 1.0 (0.94), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
AMN Healthcare Services AMN	FY2025	$2.7B	-$95.7M	-3.5%	$1.4B	25/100
InnovAge Holding Corp. INNV	FY2026	$989.7M	-$2.5M	-0.3%	$1.2B	48/100
The Pennant Group, Inc. PNTG	FY2025	$947.7M	$29.6M	3.1%	$1.4B	49/100
Nutex Health Inc. NUTX	FY2025	$875.3M	$70.8M	8.1%	$1.4B	80/100
Cross Country Healthcare Inc CCRN	FY2025	$1.1B	-$94.9M	-9.0%	$428.1M	41/100
Sonida Senior Living, Inc. SNDA	FY2025	$381.1M	-$72.5M	-19.0%	$1.7B	47/100

Where AMN Healthcare Services Ranks

Frequently Asked Questions

What is AMN Healthcare Services's annual revenue?

AMN Healthcare Services (AMN) reported $2.7B in total revenue for fiscal year 2025. This represents a -8.5% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is AMN Healthcare Services's revenue growing?

AMN Healthcare Services (AMN) revenue declined by 8.5% year-over-year, from $3.0B to $2.7B in fiscal year 2025.

Is AMN Healthcare Services profitable?

No, AMN Healthcare Services (AMN) reported a net income of -$95.7M in fiscal year 2025, with a net profit margin of -3.5%.

What is AMN Healthcare Services's EBITDA?

AMN Healthcare Services (AMN) had EBITDA of $101.1M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does AMN Healthcare Services have?

As of fiscal year 2025, AMN Healthcare Services (AMN) had $34.0M in cash and equivalents against $767.1M in long-term debt.

What is AMN Healthcare Services's gross margin?

AMN Healthcare Services (AMN) had a gross margin of 28.3% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is AMN Healthcare Services's operating margin?

AMN Healthcare Services (AMN) had an operating margin of -2.0% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is AMN Healthcare Services's net profit margin?

AMN Healthcare Services (AMN) had a net profit margin of -3.5% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is AMN Healthcare Services's return on equity (ROE)?

AMN Healthcare Services (AMN) has a return on equity of -14.9% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is AMN Healthcare Services's free cash flow?

AMN Healthcare Services (AMN) generated $233.8M in free cash flow during fiscal year 2025. This represents a -2.4% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is AMN Healthcare Services's operating cash flow?

AMN Healthcare Services (AMN) generated $269.5M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are AMN Healthcare Services's total assets?

AMN Healthcare Services (AMN) had $2.1B in total assets as of fiscal year 2025, including both current and long-term assets.

What are AMN Healthcare Services's capital expenditures?

AMN Healthcare Services (AMN) invested $35.6M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How many shares does AMN Healthcare Services have outstanding?

AMN Healthcare Services (AMN) had 39M shares outstanding as of fiscal year 2025.

What is AMN Healthcare Services's current ratio?

AMN Healthcare Services (AMN) had a current ratio of 0.94 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

What is AMN Healthcare Services's debt-to-equity ratio?

AMN Healthcare Services (AMN) had a debt-to-equity ratio of 1.19 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is AMN Healthcare Services's return on assets (ROA)?

AMN Healthcare Services (AMN) had a return on assets of -4.6% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is AMN Healthcare Services's P/E ratio?

AMN Healthcare Services (AMN) trades at 13.5x earnings, its market capitalization divided by net income of $104.9M net income, trailing 12 months to June 30, 2026. The market capitalization is $1.4B as of Oct 14, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is AMN Healthcare Services's price-to-sales ratio?

AMN Healthcare Services (AMN) trades at 0.4x sales, its market capitalization divided by revenue of $3.4B revenue, trailing 12 months to June 30, 2026. The market capitalization is $1.4B as of Oct 14, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is AMN Healthcare Services's Altman Z-Score?

AMN Healthcare Services (AMN) has an Altman Z-Score of 2.59, placing it in the Grey Zone (moderate risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is AMN Healthcare Services's Piotroski F-Score?

AMN Healthcare Services (AMN) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are AMN Healthcare Services's earnings high quality?

AMN Healthcare Services (AMN) reported a net loss of $95.7M while generating $269.5M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can AMN Healthcare Services cover its interest payments?

AMN Healthcare Services (AMN) reported an operating loss of $55.5M against $45.6M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is AMN Healthcare Services?

AMN Healthcare Services (AMN) scores 25 out of 100 on our Financial Health Score, indicating weak standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.